Schmidt S, Linington C, Zipp F, Sotgiu S, de Waal Malefyt R, Wekerle H, Hohlfeld R
Department of Neuroimmunology, Max-Planck Institute, Martinsried, Germany.
Brain. 1997 Aug;120 ( Pt 8):1437-45. doi: 10.1093/brain/120.8.1437.
The adoptive transfer of autoreactive S100 beta-specific T cells induces experimental autoimmune panencephalomyelitis and uveoretinitis in the Lewis rat, mimicking the distribution of lesions seen in a subset of patients with multiple sclerosis. We studied the frequency and functional properties of the human T-cell response to S100 beta in eight patients (two relapsing-remitting multiple sclerosis, one chronic-progressive multiple sclerosis, two with multiple sclerosis and uveitis, two neuromyelitis optica, one panuveitis) and in seven healthy individuals, using bovine S100 beta for T-cell stimulation. Both in patients and controls, the frequency of S100 beta-specific T-cell responses was half of that obtained for myelin basic protein (MBP), and only 10% of that obtained using purified protein derivative (PPD). The stimulation indices obtained in response to S100 beta were also less than half those obtained with either MBP or PPD. However, four long-term S100 beta-specific T-cell lines were established and studied in more detail. The four T-cell lines all exhibited a CD4+, CD8-, T-cell receptor alpha beta + surface phenotype and secreted tumour necrosis factor-alpha, interferon-gamma, interleukin-10 and interleukin-4 upon antigenic stimulation, but they were heterogenous with respect to T-cell receptor usage; two T-cell lines expressed V beta 2, one V beta 6.7 and one V beta 13. Antigen-specificity was confirmed using bovine S100 beta beta and alpha beta-isoforms, as well as a recombinant rat S100 beta preparation. The response to S100 beta was shown to the HLA-(human leukocyte antigen-) DR-restricted for two of the S100 beta-specific T-cell lines. Human S100 beta-specific T-cell lines were cytotoxic, although to a lesser extent than MBP-specific T-cell lines derived from the same donors. The phenotypic and functional properties of human S100 beta-specific T-cell lines raise the possibility that these T cells are pathogenic, as they are in the rat. The low frequency and proliferative index of S100 beta-specific, as opposed to MBP-specific T-cell responses suggests that the T-cell response to this widely expressed calcium-binding protein is under more efficient regulatory control.
自身反应性S100β特异性T细胞的过继转移可在Lewis大鼠中诱发实验性自身免疫性全脑脊髓炎和葡萄膜视网膜炎,模拟了一部分多发性硬化症患者的病变分布情况。我们使用牛S100β刺激T细胞,研究了8例患者(2例复发缓解型多发性硬化症、1例慢性进展型多发性硬化症、2例伴有葡萄膜炎的多发性硬化症、2例视神经脊髓炎、1例全葡萄膜炎)和7名健康个体中人类T细胞对S100β的反应频率及功能特性。在患者和对照中,S100β特异性T细胞反应的频率均为髓鞘碱性蛋白(MBP)反应频率的一半,仅为使用纯化蛋白衍生物(PPD)所获反应频率的10%。针对S100β产生的刺激指数也不到针对MBP或PPD所获刺激指数的一半。然而,我们建立了4个长期的S100β特异性T细胞系并进行了更详细的研究。这4个T细胞系均表现出CD4 +、CD8 -、T细胞受体αβ +表面表型,在抗原刺激下分泌肿瘤坏死因子-α、干扰素-γ、白细胞介素-10和白细胞介素-4,但它们在T细胞受体使用方面存在异质性;2个T细胞系表达Vβ2,1个表达Vβ6.7,1个表达Vβ13。使用牛S100ββ和αβ同工型以及重组大鼠S100β制剂证实了抗原特异性。对于其中2个S100β特异性T细胞系,显示出对S100β的反应受HLA -(人类白细胞抗原-)DR限制。人类S100β特异性T细胞系具有细胞毒性,尽管程度低于源自相同供体的MBP特异性T细胞系。人类S100β特异性T细胞系的表型和功能特性增加了这些T细胞与大鼠中的T细胞一样具有致病性的可能性。与MBP特异性T细胞反应相反,S100β特异性T细胞反应的频率和增殖指数较低,这表明对这种广泛表达的钙结合蛋白的T细胞反应受到更有效的调节控制。